Based on the evidence, the USPSTF continues to recommend against screening of asymptomatic adults and adolescents<\/p>\n<\/h3>\n
By Elana Gotkine HealthDay Reporter<\/b><\/p>\n
<\/b><\/p>\n
TUESDAY, Feb. 14, 2023 (HealthDay News) — The U.S. Preventive Services Task Force (USPSTF) recommends against routine screening for genital herpes simplex virus (HSV) among asymptomatic adults and adolescents. This recommendation forms the basis of a final recommendation statement published in the Feb. 14 issue of the Journal of the American Medical Association<\/em>.<\/p>\n Gary N. Asher, M.D., M.P.H., from the University of North Carolina at Chapel Hill, and colleagues conducted a literature review to update the 2016 USPSTF recommendation against routine screening for genital herpes infection in asymptomatic adolescents and adults. A total of 3,119 abstracts and 64 full-text articles were reviewed. The researchers found no new eligible studies for any of the seven key questions. One new diagnostic accuracy study was identified; however, this study was excluded due to poor quality.<\/p>\n Based on these findings, the USPSTF reaffirms the conclusion that the harms outweigh the benefits for population-based screening for genital HSV infection in asymptomatic adolescents and adults, including pregnant persons. For asymptomatic individuals, the USPSTF recommends against routine serologic screening for genital HSV infection (D recommendation).<\/p>\n “The task force found that screening for genital herpes in people without signs and symptoms does not improve their overall health,” task force member James Stevermer, M.D., said in a statement. “This is due in large part to the fact that the tests used to screen for genital herpes have limitations and a significant chance that the results will say a person has the infection when they do not.”<\/p>\n Evidence Report<\/a><\/p>\n Final Recommendation Statement<\/a><\/p>\n